Larvol Delta - aTyr-Pharma-Announces-FDA-Orphan-Drug-Designation-for-Efzotimod-ATYR1923-for-Treatment-of-Systemic-Sclerosis

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2022/04/13/2421843/0/en/aTyr-Pharma-Announces-FDA-Orphan-Drug-Designation-for-Efzofitimod-ATYR1923-for-Treatment-of-Systemic-Sclerosis.html

Apr 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next